Burkley Jensen, DPM
Foot & Ankle Surgery · Safford, AZNPI 1326306630
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Sioux Surgical Inc at 28.8% of the total. Reporting peaked in 2021 at $1,901 and has fallen 90.6% since, to $179 in 2025.
Across 94 payments — averaging $46.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sioux Surgical Inc$1K
- Medical Device Business Services, Inc.$713
- Arthrex$494
- Smith+Nephew$354
- Johnson & Johnson$301
- Stryker$215
- plus $1K from 16 others
What the payments were for
- Travel & lodging$1,10525%
- Food & beverage$2,10248%
- Education$1,20027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sioux Surgical Inc | 3 | $1,270 |
| Medical Device Business Services, Inc. | 3 | $713 |
| Arthrex | 7 | $494 |
| Smith+Nephew | 23 | $354 |
| Johnson & Johnson(2 entities) | 9 | $301 |
| Stryker | 7 | $215 |
| Kerecis Limited | 4 | $207 |
| Organogenesis Inc. | 7 | $169 |
| Mimedx Group, Inc. | 8 | $161 |
| Melinta Therapeutics, LLC | 7 | $102 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $101 |
| Averitas Pharma Inc. | 3 | $73 |
| Boston Scientific | 1 | $41 |
| Integra Lifesciences Corporation | 2 | $36 |
| KCI USA, Inc. | 1 | $31 |
| AbbVie(2 entities) | 2 | $28 |
| AstraZeneca | 1 | $27 |
| BD | 1 | $22 |
| Bioventus LLC | 1 | $19 |
| Globus Medical | 1 | $18 |
| RSW Medical Company, Inc. | 1 | $14 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,407 in reported general payments places this provider in the 65th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 11 | $250 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $183 |
| Cephalexin | 16 | $112 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $97 |
| Methylprednisolone | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Safford
- Ryan ScottPhoenix$1.1M
- Jeffrey McAlisterScottsdale$578K
- Jeffrey HolmesPhoenix$509K
- Myron HansenChandler$480K
- Scott MalingMesa$382K
- Melissa GalliPhoenix$324K
- Geoffrey LandisTucson$307K
- Zachary FlynnPhoenix$239K
- Bruce WerberScottsdale$177K
- Keith GossChandler$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.